CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $76.26M, above the global median of $18.73M
- FinancialsAltman Z-Score 2.69: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.85BCNY873.16M · vs all stocks (USD)
Revenue (TTM)
1.13BCNY168.19M · vs all stocks (USD)
Profit Margin
-10.41%Beta
-0.0060xvs all stocks
52-Week Change
-14.78%vs all stocks
Market Capitalization
5.85BCNY873.16M · vs all stocks (USD)
Enterprise Value
6.39BCNY952.73M · vs all stocks (USD)
Forward P/E
14.48xPrice to Sales (TTM)
5.19xPrice to Book (MRQ)
2.27xEnterprise to Revenue
5.67xEnterprise to EBITDA
177.75xGross Margin
23.85%Profit Margin
-10.41%Operating Margin
-25.42%Return on Assets (TTM)
-1.05%Return on Equity (TTM)
-4.55%Revenue (TTM)
1.13BCNY168.19M · vs all stocks (USD)
Revenue per Share (TTM)
1.92CNYUpdated Sep 19, 2026Quarterly Revenue Growth
-18.50%Gross Profit (TTM)
454.37MCNY67.77M · vs all stocks (USD)
EBITDA (TTM)
65.06MCNY9.70M · vs all stocks (USD)
Net Income (TTM)
-117.42MCNY-17.51M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-31.90%Operating Cash Flow (TTM)
621.40MCNY92.69M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
511.28MCNY76.26M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
91.66MCNYFY2025 · Dec 31, 2025Revenue
1.12BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
726.95MCNYFY2025 · Dec 31, 2025Gross Profit
390.38MCNYFY2025 · Dec 31, 2025Operating Income
-54.66MCNY-8.15M · vs all stocks (USD)
Pre-tax Income
-159.23MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.67MCNYFY2025 · Dec 31, 2025Net Income
-171.90MCNYFY2025 · Dec 31, 2025EBIT
-121.15MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
65.06MCNYFY2025 · Dec 31, 2025Research & Development
59.16MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
202.29MCNYFY2025 · Dec 31, 2025Other Operating Expenses
19.68MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
11.48MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
38.08MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2700CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2700CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
619.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
619.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-171.90MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
4.66MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
334.19MCNYFY2025 · Dec 31, 2025Free Cash Flow
45.29MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
534.03MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-171.90MCNYFY2025 · Dec 31, 2025Other Non-cash Items
41.32MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
486.88MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-22.11MCNYFY2025 · Dec 31, 2025Capital Expenditures
-288.90MCNYFY2025 · Dec 31, 2025Purchase of Investments
-6.57MCNYFY2025 · Dec 31, 2025Sale of Investments
14.73MCNYFY2025 · Dec 31, 2025Other Investing Activity
9.46MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-271.28MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
891.56MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.05BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-47.70MCNYFY2025 · Dec 31, 2025Other Financing Charges
268.08MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
57.13MCNYFY2025 · Dec 31, 2025Shares Outstanding
611.69MSharesUpdated Sep 19, 2026Float Shares
284.38MSharesUpdated Sep 19, 2026% Held by Insiders
56.66%vs all stocks
% Held by Institutions
1.35%vs all stocks
Total Cash (MRQ)
568.77MCNY84.84M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.9300CNYUpdated Sep 19, 2026Total Debt (MRQ)
1.02BCNY151.93M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3829xCurrent Ratio (MRQ)
1.28xBook Value per Share (MRQ)
4.21CNYUpdated Sep 19, 2026Total Assets
4.39BCNY655.00M · vs all stocks (USD)
Total Current Assets
1.65BCNYFY2025 · Dec 31, 2025Total Liabilities
1.78BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.74BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
432.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.35BCNYFY2025 · Dec 31, 2025Cash
534.03MCNYFY2025 · Dec 31, 2025Cash Equivalents
12.52MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
546.55MCNYFY2025 · Dec 31, 2025Accounts Receivable
619.08MCNYFY2025 · Dec 31, 2025Inventory
232.67MCNYFY2025 · Dec 31, 2025Accounts Payable
339.46MCNYFY2025 · Dec 31, 2025Short-term Debt
801.51MCNYFY2025 · Dec 31, 2025Other Current Liabilities
30.45MCNYFY2025 · Dec 31, 2025Long-term Debt
183.55MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
4.27MCNYFY2025 · Dec 31, 2025Common Stock (Book)
611.69MCNYFY2025 · Dec 31, 2025Retained Earnings
1.49BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.61BCNY388.95M · vs all stocks (USD)
Treasury Stock
0.00CNYFY2025 · Dec 31, 202552-Week Low
8.53CNYUpdated Sep 19, 202652-Week High
36.24CNYUpdated Sep 19, 202652-Week Change
-14.78%vs all stocks
Beta
-0.0060xvs all stocks
50-Day MA
10.04CNYUpdated Sep 19, 2026200-Day MA
16.28CNYUpdated Sep 19, 2026Avg 10-Day Volume
8.75MSharesUpdated Sep 19, 2026Avg 30-Day Volume
10.43MSharesUpdated Sep 19, 2026Diluted EPS (TTM)
-0.1900CNYUpdated Sep 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.69: safe zoneNotable
Altman Z-Score: 2.69
High earnings qualityNotable
Earnings Quality Score: 1.36
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $76.26M, above the global median of $18.73MNotable
Levered free cash flow (USD): 76,261,880.429Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Hpgc Renmintongtai Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guizhou Sanli Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shouyao Holdings Beijing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wuhan Keqian Biology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sana Biotechnology, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Chongqing Pharscin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ardelyx Inc.
Tier 1ProductionApproval-Gated PipelineRule
Theravance Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Beijing SL Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Eis Eczacıbaşı İlaç ve Sanayi A.Ş.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Guomai Technologies Inc.
1 interpretationPartial Recovery After Sharp Decline
Shinry Technologies Co., Ltd.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Castech Inc.
2 interpretationsPartial Recovery After Sharp DeclineUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated